Journal article
Use of irinotecan in secondline treatment of metastatic colorectal carcinoma
Abstract
Question: What is the role of irinotecan (Camptosar(TM), CPT-11) in the second-line treatment of metastatic colorectal carcinoma? Perspective: Evidence was collected and reviewed by one member of the Gastro-intestinal Cancer Disease Site Group (DSG) of the Cancer Care Ontario Practice Guidelines Initiative. The Gastro-intestinal Cancer DSG comprises of medical and radiation oncologists, surgeons, and epidemiologists. Community representatives …
Authors
Figueredo A; Moore M; Germond C; Kocha W; Maroun J; Zwaal C; Aboola O; Cummings B; De Nardi F; Earle C
Journal
Current Oncology, Vol. 7, No. 1, pp. 29–36
Publication Date
January 1, 2000